Advice

following an abbreviated submission:

testosterone gel (Testavan®) is accepted for restricted use within NHSScotland.

Indication under review: testosterone replacement therapy for adult male hypogonadism, when testosterone deficiency has been confirmed by clinical features and biochemical tests.

SMC restriction: patients requiring a transdermal delivery system.

Testosterone (Testavan®) is an alternative to another testosterone transdermal preparation and costs less. 

Download detailed advice356KB (PDF)

Download

Medicine details

Medicine name:
testosterone (Testavan)
SMC ID:
SMC2152
Indication:
For replacement therapy for adult male hypogonadism, when testosterone deficiency has been confirmed by clinical features and biochemical tests.
Pharmaceutical company
Ferring Pharmaceuticals Ltd
BNF chapter
Endocrine system
Submission type
Abbreviated
Status
Restricted
Date advice published:
08 April 2019